IN ADULT PATIENTS WITH TARDIVEDYSKINESIA (TD)
results you can see1
Not an actual patient
~70% of patients on INGREZZA®
(valbenazine) capsules 80 mg saw
reductions in their uncontrolled
movements at 6 weeks1,2,a
The only once-daily treatment for TD1
See how convenient it can be for your patients to start INGREZZA.
There are many paths to INGREZZA
Discover support to help your patients start INGREZZA.
a Post hoc analysis included patients who had a baseline and a Week 6 AIMS total score. Reduction in uncontrolled movements as assessed by ≥1-point decrease in AIMS total score.
AIMS, Abnormal Involuntary Movement Scale.
Take the TD challenge
Get a deeper understanding of tardive dyskinesia, its impact, and differential diagnosis.
REFERENCES: 1. INGREZZA [package insert]. San Diego, CA: Neurocrine Biosciences, Inc; 2020. 2. Data on file. Neurocrine Biosciences, Inc.